The global sales of disposable bronchoscopes is estimated to be worth USD 819.1 million in 2024 and anticipated to reach a value of USD 2,683.7 million by 2034. Sales are projected to rise at a CAGR of 12.6% over the forecast period between 2024 and 2034. The revenue generated by disposable bronchoscopes in 2023 was USD 727.5 million.
Disposable bronchoscopes are single-use endoscopic devices utilized for the diagnosis and treatment of conditions relating to the respiratory system. They find their application in many hospitals, clinics, and diagnostic centers. The instruments are used to manage airways, extract foreign bodies, obtain bio-specimen sampling, and provide visualization of airways. Hospital segment contributed 63.5% share in revenue growth.
Global Disposable Bronchoscopes Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 727.5 million |
| Estimated Size, 2024 | USD 819.1 million |
| Projected Size, 2034 | USD 2,683.7 million |
| Value-based CAGR (2024 to 2034) | 12.60% |
Chronic obstructed pulmonary disease, asthma, lung cancer, considerable respiratory infections, and others are becoming increasingly prevalent, driven by trends in aging populations, urbanization, air pollution, and changes in lifestyle. Disposable bronchoscopes are an important part of the diagnosis and treatment process for patients with such pathologies.
Disposable bronchoscopes are used for air passage inspection, biopsy sampling, clearing of mucus, and removal of foreign bodies with decreased risks of cross-contamination, as opposed to multiple-use devices.
Minimally invasive procedures have been the trend of healthcare services as they replace the traditional open surgeries. Disposable bronchoscopes enable quick recovery and less discomfort to the patients since the procedures involve less complication.
The COVID-19 pandemic has highlighted the associated risk in the use of reusable medical devices, mainly the risk of contamination leading to hospital-acquired infections. Consequently, there has been increased interest in the disposable alternatives, which totally avert the risk of cross-contamination between patients.
Furthermore, advancements in technology bring enhancement in the performance of devices, enhanced imaging capabilities, and comfort to patients. These have contributed to a further increase in the demand for disposable bronchoscopes. Disposable devices are increasingly being used in healthcare facilities to sustain patient care and operational efficiency.
The growth of the disposable bronchoscope market will continue because of the need to manage this fast-growing burden of respiratory diseases to healthcare systems across the world. This is based on the need for safe and effective respiratory diagnostics and interventions that ensure timely treatment with an accurate diagnosis while minimizing infectious complications for the patient.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The table below provides a detailed comparison of the Compound Annual Growth Rate (CAGR) variations for the global disposable bronchoscopes market, spanning from the base year (2023) to the current year (2024) over the first half of the year.
This analysis highlights significant shifts in market dynamics and identifies key trends in revenue generation, offering stakeholders crucial insights into the market's progression over the examined period. The first half (H1) includes January to June, while the second half (H2) comprises July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 13.4% (2023 to 2033) |
| H2 | 13.0% (2023 to 2033) |
| H1 | 12.6% (2024 to 2034) |
| H2 | 12.2% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 12.6% in the first half and remain relatively moderate at 12.2% in the second half. In the first half (H1) the market witnessed a decrease of 80 BPS and in the second half (H2) also, the market witnessed a decrease of 80 BPS.
Operational Efficiency and Cost Effectiveness drives the demand for Disposable Bronchoscopes
Sterilization and the need for reprocessing are dispelled by disposable bronchoscopes, reducing the labor cost of workers, the cost of equipment maintenance, and the chemical agents used to clean them. In this way, operational processes in healthcare facilities are streamlined to save time and resources.
It can also reduce the risk of infections due to sterilization failure of the reusable devices, which sometimes result in very costly healthcare-associated infections. The cases of HAIs can drastically be brought down if a new, sterile bronchoscope is used on each patient, hence evading healthcare facilities from treatment costs associated with a raised burden of disease.
Furthermore, single-use bronchoscopes, compared to reusable devices, have a higher per-unit upfront cost that might be offset by long-term savings in operational and infection control cost.
As healthcare providers quite well know, in the long term, reducing the complication of infections will lead to a decrease in length of stay and reduced usage of antibiotics, hence a reduction in expenditures by institutions in healthcare.
Moreover, advance technologies in manufacturing and economies of scale are gradually bringing down the cost of disposable bronchoscopes, hence making them more affordable and within reach of more healthcare facilities across the world.
Increasing Geriatric Population fuels the Market Growth of Disposable Bronchoscopes
As people age, they are more likely to be prone to respiratory diseases like COPD, pneumonia, and lung cancer. Such conditions require frequent diagnostic and therapeutic bronchoscopy procedures. Disposable bronchoscopes have a number of advantages that give them great potential for healthcare care needs in the elderly.
Besides, the devices eliminate the risk of cross-contamination by virtue of reuse, especially in vulnerable populations whose systems are weak and therefore always susceptible. Consequently, this will reduce healthcare-associated infections and diminish the complication during or after procedures.
Moreover, the already heightened emphasis of healthcare providers and institutions on patient safety and adherence to rigid standards of healthcare is likely to be strengthened by sterile, single-use devices, of which disposable bronchoscopes are a key component.
As the aging population continues to rise around the world, disposable bronchoscopes will receive further impetus, as there happens to be greater demand for effectual respiratory care solutions for better patient outcomes, hence helping to reduce costs accrued from complications or infections in treatment.
Increasing demand for Minimal Invasive Surgery Increased Sale of Disposable Bronchoscopes
Thus, minimally invasive techniques have been increasingly sought after against traditional surgical approaches due to the numerous potential benefits in terms of quick recovery, shorter hospitalization, and fewer complications, all leading to improved patient outcomes. Disposable bronchoscopes are critical for facilitating minimally invasive respiratory procedures related to biopsy sampling, foreign body retrieval, and airway management.
Quite unlike reusable bronchoscopes, which have to be carefully sterilized after every use, disposable bronchoscopes are single-use devices that absolutely eliminate the risk of interpatient cross-contamination and infection. This single characteristic has an additional ounce of attraction in the case of minimally invasive procedures where the maintenance of a sterile environment is crucial in avoiding post-operative complications.
Advances in the technology and design of single-use bronchoscopes have increased functionality during complex procedures while ensuring quality imaging and, at the same time, good maneuverability.
With the global trend toward minimally invasive procedures, coupled with patient inclination and developments in medical technology, the market for disposable bronchoscopes will keep growing in tandem with changing health needs.
High Upfront Cost Restrict Disposable Bronchoscopes Market Growth
The upfront investment should be factored into consideration by healthcare facilities looking to see the feasibility of disposable bronchoscopes. Although disposable bronchoscopes dispense with the risks and enormous costs of reprocessing and sterilization procedures associated with reusable instruments, their purchase cost can be several times higher than the former.
This higher upfront cost may immediately pose an adoption barrier to many hospitals and clinics, especially when their budgets are tightly constrained, as is usually the case in resource-limited settings or regions where the budgets for health generally are constrained.
There are trade-offs that will have to be assessed at decision-making levels between this initial expenditure and probable long-term operational cost savings and mitigation of HAIs risks.
Manufacturing technologies and economies of scale will continuously bring down production costs for disposable bronchoscopes by the manufacturers and healthcare providers. The value proposition of the disposable bronchoscope regarding better patient safety, operational efficiency, and quality of healthcare could be shown by overcoming the initial cost hurdle.
Principal Consultant
The global disposable bronchoscopes industry recorded a CAGR of 9.6% during the historical period between 2019 and 2023. The growth of disposable bronchoscopes industry was positive as it reached a value of USD 727.5 million in 2023 from USD 439.2 million in 2019.
Infection prevention is one of the most focused areas within healthcare institutions due to the COVID-19 pandemic. Single-use, disposable bronchoscopes provide a sterile solution to help significantly decrease the risk of cross-contamination associated with reusable devices and reduce the incidence of HAIs.
Recently, minimally invasive procedures have been performed in health institutions to ensure better recovery and shorter recovery time for patients. Disposable bronchoscopes provide convenience for such procedures by giving an easy, ready-to-go option, avoiding complex steps of reprocessing that improve operational efficiency in clinical workflow.
Improvements in technology have meant that the design features of disposable bronchoscopes are now better with regard to imaging quality, maneuverability, and ergonomic benefits for the treating healthcare professional.
This way, innovations make the use of disposable bronchoscopes more preferred for diagnostic and therapeutic interventions in respiratory care. Moreover, the demand for disposable bronchoscopes is influenced by regulatory guidelines and resultant standards that emphasize the use of single-use medical devices throughout all healthcare settings.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 55.40% in global market. These market leaders are characterized by high production capacity and a wide product portfolio.
These market leaders are distinguished by their developmental efforts to introduce innovative product in the market. They provide a wide range of disposable bronchoscopes. Prominent companies within tier 1 include Stryker Corporation, Smith & Nephew, Inc., and Boston Scientific Corporation.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include NeoScope Inc., Olympus Corporation, PENTAX Medical, Karl Storz GmbH & Co. KG, and Richard Wolf GmbH etc.
Compared to Tiers 1 and 2, Tier 3 companies have smaller revenue spouts and less influence. Those in Tier 3 has smaller work force and limited presence across the globe. Prominent players in the tier 3 category are AMBU A/S, NeoScope Inc., PENTAX Medical, and Others
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the disposable bronchoscopes market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia, Western Europe, Eastern Europe, and Middle East and Africa (MEA), is provided.
The United States is anticipated to remain at the forefront in North America. In Asia Pacific, China is projected to witness a CAGR of 12.3% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Canada | 6.7% |
| Germany | 3.8% |
| France | 6.3% |
| Italy | 5.6% |
| China | 12.3% |
| South Korea | 9.7% |
| Japan | 5.0% |
Germany’s disposable bronchoscopes market is poised to exhibit a CAGR of 3.8% between 2024 and 2034. Currently, it holds the highest share in the European market, and the trend is expected to continue during the forecast period.
The cases of cancers are increasingly prevalent in Germany. According to data provided by Global Cancer Observatory, 2018, cases for new patients with cancer were approximately 498 000 (number of new cases).
Fast forward to 2022, that number has increased to 605,805, while the total prevalent cases stand at 1,886,716 (5-year). This rising rate of diagnosis drives the demand for disposable endoscopes since their application prevails in most treatments and diagnostic procedures.
Germany also has a well-established healthcare system that offers its population universal health insurance coverage with comprehensive benefits.
The country's government and insurance providers have a very conducive Medicare and private insurance system with good reimbursement policies for advanced medical equipment, hence making disposable endoscopes more economically viable for hospitals and clinics. The confluence of the above factor results in boos the market growth in Germany.
North America, spearheaded by the USA currently holds around 25.0% share of the global disposable bronchoscopes industry. North America’s market is anticipated to grow at a CAGR of 3.8% throughout the forecast period.
According to American Cancer Society in 2024 there were 234,580 new lung cancer cases and the death tool for the same indication was 125,070. The number of geriatric population have been increasing as there have rise in life expectancy with the advancement in healthcare technology.
As per the data from Population Reference Bureau, the American population of age group greater than 65 years is projected to increase from 58 million in 2022 to 82 million in 2050. As the lung cancer mainly occur in elder patient. This growing aging population is expected to further increasing the total lung cancer patient count.
When looking from the supply side United States is also characterized by the presence of major healthcare companies. There are around 6,500 MedTech companies in the Country.
There are 6120 hospital in United States as reported in 2023. So the comprehensive environment of growing patient population, large number of MedTech companies and significantly large number of healthcare service provider is contributing to the growth of disposable bronchoscope in United States.
The COVID-19 pandemic has enhanced the need for infection control in China. The disposable bronchoscope removes the risk of cross-contamination, thereby addressing one of the prime safety concerns of the patient. The Chinese government has regulations and guidelines supporting single-use medical devices, like disposable bronchoscopes.
These regulations are included in broader efforts aimed at raising the level of health care and making a dent in the burden of nosocomial infections that is exacting on hospitals and clinics across the country.
Furthermore, large investments made by China in the development of healthcare infrastructure, primarily in urban regions, have created demand for high-end medical devices, including disposable bronchoscopes. These instruments are of prime importance if respiratory conditions are to be diagnosed and treated effectively and safely in new hospitals, clinics, and diagnostic centers.
Continuous improvements in the design of disposable bronchoscopes, such as enhanced imaging, better ergonomics, and functionality, increase their adoption among Chinese healthcare providers. Hence making disposable bronchoscopes increasingly attractive in the Chinese healthcare market.
The section contains information about the leading segments in the industry. By end user, the hospitals segment is estimated to contribute 63.50% market share in 2024.
| Material | Hospitals |
|---|---|
| Value Share (2024) | 63.50% |
According to the stats from American Hospital Association there where 6120 hospitals across the nation in 2023 which accounted for around 33.6 million admissions. Similarly in other part of the world also hospital account for majority share in healthcare service provider.
Because hospital is a comprehensive establishment which offer both short term and long term care, with specialist form diverse specialty. Hospitals in general have larger resource at disposal as compared to other clinics and diagnostic centers.
The major factor that contributes to the dominance of hospitals in the market is the patient volume handled by it. This large volume inherently increase the demand for all the medical supplies including disposable bronchoscope.
Another aspect of this can be related to the greater chances of cross contamination, which in turn increases the preference of disposable bronchoscope. Hospitals also offer better reimbursement policies through insurance and government programs. Hence, all the aforementioned factor contributes to the dominance of hospital in disposable bronchoscopes market.
Key players operating in the disposable bronchoscopes market are investing in product development to stand out in the completion and offer better experience for clinicians and patients.
Large established market player are incorporating strategies such as merger, acquisition, and collaboration to gain a competitive edge. The main cornerstone for the market player to grow in the market is to focus on patient experience and cost effectiveness of the product.
Recent Industry Developments in Disposable Bronchoscopes Market
In terms of end user, the industry is divided into hospitals, clinics, and diagnostic centers.
Key countries of North America, Latin America, East Asia, South Asia, Western Europe, Eastern Europe, and Middle East and Africa (MEA), have been covered in the report.
The global disposable bronchoscopes industry is projected to witness CAGR of 12.60% between 2024 and 2034.
The global disposable bronchoscopes industry stood at USD 727.5 million in 2023.
The global disposable bronchoscopes industry is anticipated to reach USD 2,683.7 million by 2034 end.
India is set to record the highest CAGR of 13.90% in the assessment period.
The key players operating in the global disposable bronchoscopes industry include AMBU A/S, Boston Scientific Corporation, Fujifilm Holdings Corporation, Karl Storz GmbH & Co. KG, NeoScope Inc., Olympus Corporation, PENTAX Medical, Richard Wolf GmbH, Stryker Corporation, and Smith & Nephew, Inc.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 5.1. By End User 5.2. By Region 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 6.1. Hospitals 6.2. Clinics 6.3. Diagnostic Centers 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 7.1. North America 7.2. Latin America 7.3. East Asia 7.4. South Asia and Pacific 7.5. Western Europe 7.6. Eastern Europe 7.7. Middle East and Africa 8. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 9. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 10. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Sales Forecast 2024 to 2034 by End User, for 30 Countries 16. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 17. Company Profile 17.1. AMBU A/S 17.2. Boston Scientific Corporation 17.3. Fujifilm Holdings Corporation 17.4. Karl Storz GmbH & Co. KG 17.5. NeoScope Inc. 17.6. Olympus Corporation 17.7. PENTAX Medical 17.8. Richard Wolf GmbH 17.9. Stryker Corporation 17.10. Smith & Nephew, Inc.
Explore Healthcare Insights
View Reports
Disposable Bronchoscopes Market
